Quality of life outcomes in children with Hirschsprung disease

Lucy Collins1, Brennan Collis1, Misel Trajanovska2

  • 1Department of Paediatric Surgery, The Royal Children's Hospital, Melbourne, Australia; Department of Paediatrics, University of Melbourne, Melbourne, Australia.

Journal of Pediatric Surgery
|September 21, 2017
PubMed

Insights

Children with Hirschsprung disease (HD) experience reduced psychosocial quality of life (QoL) and functional outcomes. Fecal incontinence significantly impacts both physical and psychosocial QoL in HD patients.

Area of Science:

  • Pediatric surgery
  • Gastroenterology
  • Quality of Life Research

Background:

  • Morbidity is common after Hirschsprung disease (HD) repair.
  • Quality of life (QoL) outcomes in children with HD are inconsistently reported.
  • Validated questionnaires are needed to assess QoL in HD patients.

Purpose of the Study:

  • To measure QoL outcomes in children with Hirschsprung disease.
  • To identify factors affecting QoL in HD patients.
  • To compare QoL outcomes with healthy population controls.

Main Methods:

  • Prospective cohort study (Level II evidence) of 60 HD patients (2004-2013).
  • Parents completed validated questionnaires: PedsQL, FIC QOL, Baylor Continence Scale, Cleveland Clinic Constipation Scoring System, and Vancouver Dysfunctional Elimination Syndrome Survey.
  • Results compared with published healthy population data.

Main Results:

  • Significant reduction in psychosocial QoL (social and emotional) compared to healthy children (p=0.03).
  • Psychosocial functioning negatively correlated with age, fecal incontinence, constipation, and dysfunctional elimination.
  • Fecal incontinence also reduced physical functioning QoL (p=0.007); HD patients had higher incontinence rates (p<0.01).

Conclusions:

  • Children with Hirschsprung disease exhibit significantly diminished psychosocial QoL.
  • Functional outcomes, including continence, are significantly impaired in HD patients.
  • Fecal incontinence is a key factor negatively impacting QoL in this population.
Abstract

Related Concept Videos

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
977
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
829
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
1.5K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
353
Assessment of the Gastrointestinal System II: Health Perception Pattern01:29

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
532
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
924